Emergent lands $20M contract to develop chemical weapon antidote

Gaithersburg ’s Emergent BioSolutions Inc. just added another task to its ever-growing to-do list: Develop a device to stop seizures caused by chemical weapons. The company, which has two manufacturing sites in Baltimore, has secured about $20 million from the Department of Defense to design an auto-injector — a shot that can be given easily without medical training — to administer seizure drug diazepam, Emergent (NYSE: EBS) announced Thursday. The product would reverse the effects of nerve…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news